Prudential Financial’s Loxo Oncology, Inc LOXO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-2,821
Closed -$395K 2505
2018
Q4
$395K Sell
2,821
-2,985
-51% -$453K ﹤0.01% 2065
2018
Q3
$992K Sell
5,806
-21,474
-79% -$3.61M ﹤0.01% 1873
2018
Q2
$4.73M Buy
27,280
+24,730
+970% +$3.72M 0.01% 1249
2018
Q1
$294K Sell
2,550
-35,520
-93% -$3.78M ﹤0.01% 2156
2017
Q4
$3.29M Buy
38,070
+320
+0.8% +$26.7K ﹤0.01% 1335
2017
Q3
$3.48M Sell
37,750
-29,770
-44% -$2.31M 0.01% 1299
2017
Q2
$5.42M Buy
+67,520
New +$3.74M 0.01% 1105

Other funds holding LOXO

Prudential Financial's LOXO Position: Q1 2019 in Review

Prudential Financial sold out of Loxo Oncology, Inc (LOXO) in Q1 2019, closing a stake of 2,821 shares — an estimated $395K sold.

Prudential Financial first reported a position in LOXO in Q2 2017 and held it in 7 quarters. The position peaked at $5.42M in Q2 2017. 1 fund tracked by Wall St. Rank holds LOXO as of Q1 2019.

  • Prudential Financial reported no remaining Loxo Oncology, Inc position as of Q1 2019 after selling out during the quarter.
  • Prudential Financial sold 2,821 Loxo Oncology, Inc shares in Q1 2019, an estimated $395K.
  • Prudential Financial first reported a position in Loxo Oncology, Inc in Q2 2017 and held it in 7 quarters.
  • Prudential Financial's Loxo Oncology, Inc position peaked at $5.42M in Q2 2017.
  • 1 fund tracked by Wall St. Rank held Loxo Oncology, Inc as of Q1 2019.

Based on Prudential Financial's 13F filing for Q1 2019, filed 15 May 2019.